Report Detail
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Opioids Agonist Drugs Market 2018, Forecast to 2023
- RnM2733557 |
- 17 February, 2020 |
- Global |
- 107 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Market Overview
The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019.
The Opioids Agonist Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Opioids Agonist Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Opioids Agonist Drugs market has been segmented into
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
By Application, Opioids Agonist Drugs has been segmented into:
Pain Management
Cough Treatment
Diarrhea Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids Agonist Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids Agonist Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids Agonist Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Opioids Agonist Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Opioids Agonist Drugs Market Share Analysis
Opioids Agonist Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioids Agonist Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids Agonist Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Opioids Agonist Drugs are:
Purdue Pharma
Egalet Corporation
Janssen Pharmaceuticals, Inc
Titan pharmaceuticals
Mallinckrodt Pharmaceuticals
Boehringer Ingelheim
Allergan, Plc
Sun Pharmaceuticals
Sanofi
Endo Pharmaceuticals Inc.
Pfizer Inc
Among other players domestic and global, Opioids Agonist Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Agonist Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Agonist Drugs, with price, sales, revenue and global market share of Opioids Agonist Drugs in 2018 and 2019.
Chapter 3, the Opioids Agonist Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Agonist Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Opioids Agonist Drugs Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Overview: Global Opioids Agonist Drugs Revenue by Type: 2015 VS 2019 VS 2025
- 1.2.2 Codeine
- 1.2.3 Fentanyl
- 1.2.4 Meperidine
- 1.2.5 Methadone
- 1.2.6 Morphine
- 1.2.7 Hydrocodone
- 1.3 Market Analysis by Application
- 1.3.1 Overview: Global Opioids Agonist Drugs Revenue by Application: 2015 VS 2019 VS 2025
- 1.3.2 Pain Management
- 1.3.3 Cough Treatment
- 1.3.4 Diarrhea Treatment
- 1.4 Overview of Global Opioids Agonist Drugs Market
- 1.4.1 Global Opioids Agonist Drugs Market Status and Outlook (2015-2025)
- 1.4.2 North America (United States, Canada and Mexico)
- 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
- 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.5 South America, Middle East & Africa
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Purdue Pharma
- 2.1.1 Purdue Pharma Details
- 2.1.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
- 2.1.3 Purdue Pharma SWOT Analysis
- 2.1.4 Purdue Pharma Product and Services
- 2.1.5 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.2 Egalet Corporation
- 2.2.1 Egalet Corporation Details
- 2.2.2 Egalet Corporation Major Business and Total Revenue (Financial Highlights) Analysis
- 2.2.3 Egalet Corporation SWOT Analysis
- 2.2.4 Egalet Corporation Product and Services
- 2.2.5 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.3 Janssen Pharmaceuticals, Inc
- 2.3.1 Janssen Pharmaceuticals, Inc Details
- 2.3.2 Janssen Pharmaceuticals, Inc Major Business and Total Revenue (Financial Highlights) Analysis
- 2.3.3 Janssen Pharmaceuticals, Inc SWOT Analysis
- 2.3.4 Janssen Pharmaceuticals, Inc Product and Services
- 2.3.5 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.4 Titan pharmaceuticals
- 2.4.1 Titan pharmaceuticals Details
- 2.4.2 Titan pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
- 2.4.3 Titan pharmaceuticals SWOT Analysis
- 2.4.4 Titan pharmaceuticals Product and Services
- 2.4.5 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.5 Mallinckrodt Pharmaceuticals
- 2.5.1 Mallinckrodt Pharmaceuticals Details
- 2.5.2 Mallinckrodt Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
- 2.5.3 Mallinckrodt Pharmaceuticals SWOT Analysis
- 2.5.4 Mallinckrodt Pharmaceuticals Product and Services
- 2.5.5 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.6 Boehringer Ingelheim
- 2.6.1 Boehringer Ingelheim Details
- 2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
- 2.6.3 Boehringer Ingelheim SWOT Analysis
- 2.6.4 Boehringer Ingelheim Product and Services
- 2.6.5 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.7 Allergan, Plc
- 2.7.1 Allergan, Plc Details
- 2.7.2 Allergan, Plc Major Business and Total Revenue (Financial Highlights) Analysis
- 2.7.3 Allergan, Plc SWOT Analysis
- 2.7.4 Allergan, Plc Product and Services
- 2.7.5 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.8 Sun Pharmaceuticals
- 2.8.1 Sun Pharmaceuticals Details
- 2.8.2 Sun Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
- 2.8.3 Sun Pharmaceuticals SWOT Analysis
- 2.8.4 Sun Pharmaceuticals Product and Services
- 2.8.5 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.9 Sanofi
- 2.9.1 Sanofi Details
- 2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
- 2.9.3 Sanofi SWOT Analysis
- 2.9.4 Sanofi Product and Services
- 2.9.5 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.10 Endo Pharmaceuticals Inc.
- 2.10.1 Endo Pharmaceuticals Inc. Details
- 2.10.2 Endo Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
- 2.10.3 Endo Pharmaceuticals Inc. SWOT Analysis
- 2.10.4 Endo Pharmaceuticals Inc. Product and Services
- 2.10.5 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
- 2.11 Pfizer Inc
- 2.11.1 Pfizer Inc Details
- 2.11.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
- 2.11.3 Pfizer Inc SWOT Analysis
- 2.11.4 Pfizer Inc Product and Services
- 2.11.5 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
- 3.1 Global Opioids Agonist Drugs Sales and Market Share by Manufacturer (2018-2019)
- 3.2 Global Opioids Agonist Drugs Revenue and Market Share by Manufacturer (2018-2019)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2019
- 3.3.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share in 2019
- 3.4 Market Competition Trend
4 Global Market Analysis by Regions
- 4.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
- 4.1.1 Global Opioids Agonist Drugs Sales and Market Share by Regions (2015-2020)
- 4.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Regions (2015-2020)
- 4.2 North America Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 4.3 Europe Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 4.4 Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 4.5 South America Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 4.6 Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
- 5.1 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Country
- 5.1.1 North America Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
- 5.1.2 North America Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
- 5.2 United States Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 5.3 Canada Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 5.4 Mexico Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
- 6.1 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Country
- 6.1.1 Europe Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
- 6.1.2 Europe Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
- 6.2 Germany Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 6.3 UK Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 6.4 France Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 6.5 Russia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 6.6 Italy Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
- 7.1 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
- 7.1.1 Asia-Pacific Opioids Agonist Drugs Sales and Market Share by Regions (2015-2020)
- 7.1.2 Asia-Pacific Opioids Agonist Drugs Revenue and Market Share by Regions (2015-2020)
- 7.2 China Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 7.3 Japan Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 7.4 Korea Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 7.5 India Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 7.6 Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 7.7 Australia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
- 8.1 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Country
- 8.1.1 South America Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
- 8.1.2 South America Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
- 8.2 Brazil Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 8.3 Argentina Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
- 9.1 Middle East & Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Country
- 9.1.1 Middle East & Africa Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
- 9.1.2 Middle East & Africa Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
- 9.2 Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 9.3 Turkey Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 9.4 Egypt Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
- 9.5 South Africa Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
- 10.1 Global Opioids Agonist Drugs Sales and Market Share by Type (2015-2020)
- 10.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2015-2020)
- 10.3 Global Opioids Agonist Drugs Price by Type (2015-2020)
11 Global Opioids Agonist Drugs Market Segment by Application
- 11.1 Global Opioids Agonist Drugs Sales Market Share by Application (2015-2020)
- 11.2 Global Opioids Agonist Drugs Revenue Market Share by Application (2015-2020)
- 11.3 Global Opioids Agonist Drugs Price by Application (2015-2020)
12 Market Forecast
- 12.1 Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2021-2025)
- 12.2 Opioids Agonist Drugs Market Forecast by Regions (2021-2025)
- 12.2.1 North America Opioids Agonist Drugs Market Forecast (2021-2025)
- 12.2.2 Europe Opioids Agonist Drugs Market Forecast (2021-2025)
- 12.2.3 Asia-Pacific Opioids Agonist Drugs Market Forecast (2021-2025)
- 12.2.4 South America Opioids Agonist Drugs Market Forecast (2021-2025)
- 12.2.5 Middle East & Africa Opioids Agonist Drugs Market Forecast (2021-2025)
- 12.3 Opioids Agonist Drugs Market Forecast by Type (2021-2025)
- 12.3.1 Global Opioids Agonist Drugs Sales Forecast by Type (2021-2025)
- 12.3.2 Global Opioids Agonist Drugs Market Share Forecast by Type (2021-2025)
- 12.4 Opioids Agonist Drugs Market Forecast by Application (2021-2025)
- 12.4.1 Global Opioids Agonist Drugs Sales Forecast by Application (2021-2025)
- 12.4.2 Global Opioids Agonist Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
- 15.2 Data Source
- 15.3 Disclaimer
Summary:
Get latest Market Research Reports on Opioids Agonist Drugs . Industry analysis & Market Report on Opioids Agonist Drugs is a syndicated market report, published as Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Opioids Agonist Drugs Market 2018, Forecast to 2023. It is complete Research Study and Industry Analysis of Opioids Agonist Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
